Phase 1 Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part voluntarily and are able to sign a consent form after fully understanding what the trial involves
- You are between 18 and 45 years old (inclusive)
- If you are male, you weigh at least 50 kg (about 110 lbs); if you are female, you weigh at least 45 kg (about 99 lbs)
- Your Body Mass Index (BMI) is between 18 and 28 kg/m²
- You are willing and able to use effective birth control (such as abstinence, condoms, an IUD, or a combination of barrier methods) from the start of screening until 6 months after your last dose of the trial drug
- Your vital signs (such as blood pressure and heart rate) and physical exam results are normal or only slightly abnormal in a way that is not medically concerning
Who may not be able to join:
- You have a history of drug allergies, specific allergic conditions (such as asthma or hives), or a known or suspected allergy to the trial drug or its ingredients
- You have taken any prescription medicines, over-the-counter medicines, herbal remedies, or health supplements in the 2 weeks before screening
- Your lab tests, ultrasound, chest X-ray, or other medical checks show results that are considered clinically significant concerns, or you have had a significant medical condition in the past 6 months (including but not limited to conditions affecting the gut, kidneys, liver, nerves, blood, hormones, lungs, immune system, mental health, or heart and blood vessels)
- You ate certain foods that can affect how the body processes medicines (such as grapefruit, dragon fruit, or mango) within 7 days before screening, or did intense exercise during that time
- You or a close blood relative (parent, sibling, or child) has a history of certain heart rhythm problems, long or short QT syndrome, unexplained sudden death before age 40, or sudden infant death syndrome
- You have abnormal levels of certain minerals in your blood (such as potassium, magnesium, or calcium) that are considered clinically significant
- You have a clinically significant abnormal heart tracing (ECG), or a specific heart rhythm measurement (QTcF) greater than 450ms
- Your kidney function, as measured by a specific calculation, falls below a certain level (confirm with trial site)
- You have or have had a chronic or active digestive condition, such as stomach ulcers, esophageal disease, intestinal inflammation, active gastrointestinal bleeding, or relevant gastrointestinal surgery
- You had a major surgery (not including diagnostic procedures) in the 6 months before screening, are planning surgery during the study, or had surgery that may affect how your body handles medicines
- You took part in another clinical trial within the 3 months before screening and actually received the trial drug in that study
- You donated blood or lost a significant amount of blood (more than 450 ml) in the 3 months before screening
- You have a history of heavy alcohol use (averaging more than 14 units per week in the past 3 months), are unable to avoid alcohol during the trial, or test positive on a breath alcohol test
- You smoked more than 5 cigarettes per day on average in the 3 months before screening
- You have a history of drug or substance abuse, or test positive on a urine drug screening
- You have specific dietary requirements that would prevent you from following the trial's standard meal plan
- You have difficulty swallowing
- You are currently breastfeeding or have a positive pregnancy test result
- You became acutely unwell or started taking new medication between your screening visit and the time you would take the first trial drug dose
- You consumed chocolate, caffeine, or foods or drinks rich in xanthines in the 24 hours before taking the first trial drug dose
- You consumed any alcohol-containing product or tested positive on a breath alcohol test in the 24 hours before taking the trial drug
- The trial doctor believes, for any other reason, that you are not suitable to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hong Zhang, The First Hospital of Jilin University
Phone: 18943642700
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adverse Events following oral doses (single, multiple and food effect)of IMM-H014 and placebo; Number of participants with abnormal laboratory tests results and abnormal physical exam findings
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.